Ginkgo Bioworks Unveils New Automation Technology for Research
Ginkgo Bioworks is making waves in the field of microbial research through its latest collaboration with the Environmental Molecular Sciences Laboratory (EMSL). The company is spearheading the deployment of its innovative Reconfigurable Automation Carts (RACs) technology, a platform aimed at transforming how EMSL explores microorganisms relevant to the bioeconomy.
Building Advanced Systems for Research Efficiency
This groundbreaking project is a significant milestone for EMSL, a facility that supports fundamental biological research related to energy production. Ginkgo Bioworks, trading under NYSE: DNA, will implement a state-of-the-art automated phenotyping platform, designed to streamline the study of microbes.
Key Features of the New System
Under a contract valued at $4.66 million, Ginkgo will construct a fully integrated workcell at EMSL. This workcell will incorporate 18 different devices, all housed within a modular anaerobic chamber, allowing scientists to perform intricate anaerobic workflows. This collaboration will empower EMSL researchers to operate complex processes remotely, greatly enhancing research efficiency.
Enhanced Throughput and Data Capture
Ginkgo's automation solutions are renowned for facilitating flexible research and development activities. The RACs technology represents a modern approach, enabling high-throughput automated laboratory operations. By utilizing a web-based software architecture that integrates seamlessly with existing lab equipment, Ginkgo is setting the stage for researchers to accelerate their discoveries.
Will Serber, General Manager of Ginkgo Automation, expressed enthusiasm for this partnership. He stated, "We are excited to support EMSL's ambitious research goals with our automation technology. Our systems are designed to empower partners like EMSL, enhancing R&D while maintaining control over critical scientific workflows." This collaboration exemplifies Ginkgo's commitment to advancing the capabilities of leading research institutions.
Looking Ahead: The Future of Microbial Research
As the new automation platform becomes operational, EMSL will be positioned to lead in microbial engineering and biodesign studies significantly. Ginkgo's partnership with EMSL exemplifies a transformative public-private initiative aimed at fostering innovation in biotechnology.
Driving Change in the Bioeconomy
The deployment of Ginkgo's RAC technology is poised to significantly improve the research landscape. By streamlining workflows, Ginkgo is not only enhancing the research capabilities of EMSL but also contributing to the broader bioeconomy framework. This collaboration could reveal new biological insights that may hold the key to future energy solutions.
Overview of Ginkgo Bioworks
Ginkgo Bioworks is at the forefront of engineering biology. They offer tools that enable easier biological engineering and provide customizable R&D solutions spanning protein engineering, nucleic acid design, and cell-free systems. Their advanced automated systems allow scientists to focus on innovation rather than manual lab work, thereby enhancing research productivity.
Ginkgo Automation plays a critical role in this endeavor, offering modular laboratory solutions that integrate seamlessly into existing workflows. The company is also working on data solutions that can harness large datasets generated through automated processes, ultimately contributing to the predictive power of AI technologies in biology.
Frequently Asked Questions
What is Ginkgo Bioworks' main objective with its new automation technology?
Ginkgo Bioworks aims to enhance the efficiency and throughput of microbial research at EMSL, facilitating groundbreaking discoveries in the bioeconomy.
How does the Reconfigurable Automation Cart (RAC) work?
The RAC technology is a modular system designed for laboratory automation, allowing researchers to operate complex workflows remotely while improving data quality and efficiency.
What benefits does this partnership bring to EMSL?
This partnership equips EMSL with advanced automation tools, streamlining their research processes and potentially accelerating discoveries in microbial engineering and bioengineering.
When will the new system be operational?
The new automation platform is expected to be fully operational at EMSL later this year, enhancing their research capabilities.
What is the broader impact of Ginkgo Bioworks’ automation on the industry?
Ginkgo's automation technology is set to drive innovation in the biotechnology sector, enabling researchers to advance knowledge in bioengineering and energy production efficiently.
